A randomised, double blind, parallel-group study of the oxidative stress lowering effect of simvastatin and atorvastatin
Phase of Trial: Phase IV
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Atorvastatin (Primary) ; Simvastatin
- Indications Hyperlipidaemia
- Focus Pharmacodynamics
- 10 Jun 2017 Biomarkers information updated
- 09 Jun 2008 Status changed from initiated to recruiting as reported by ClinicalTrials.gov.
- 09 Jun 2008 The expected completion date for this trial is now 1 Jul 2009 as reported by ClinicalTrials.gov.